Cargando…

Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation

Giant cell tumor of bone (GCTB) is a locally aggressive lesion of intermediate malignancy. Malignant transformation of GCTB is a rare event. In 2013, the humanized monoclonal antibody against receptor activator of nuclear factor-κb-Ligand (RANKL) denosumab was approved for treatment of advanced GCTB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasenfratz, Marc, Mellert, Kevin, Marienfeld, Ralf, von Baer, Alexandra, Schultheiss, Markus, Roitman, P. D., Aponte-Tinao, L. A., Lehner, Burkhard, Möller, Peter, Mechtersheimer, Gunhild, Barth, Thomas F. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952552/ https://www.ncbi.nlm.nih.gov/pubmed/33707617 http://dx.doi.org/10.1038/s41598-021-85319-x

Ejemplares similares

Characterization of Three Novel H3F3A-mutated Giant Cell Tumor Cell Lines and Targeting of Their Wee1 Pathway
por: Lübbehüsen, Christoph, et al.
Publicado: (2019)

Histomorphometric Analysis of 38 Giant Cell Tumors of Bone after Recurrence as Compared to Changes Following Denosumab Treatment
por: Arndt, Sophia, et al.
Publicado: (2023)

Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence
por: Omlor, Georg W., et al.
Publicado: (2019)

CARD9 Forms an Alternative CBM Complex in Richter Syndrome
por: Maier, Julia, et al.
Publicado: (2022)

Malignant transformation of uterine leiomyoma to myxoid leiomyosarcoma after morcellation associated with ALK rearrangement and loss of 14q
por: Holzmann, Carsten, et al.
Publicado: (2018)

Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib
por: Böhm, Michael J., et al.
Publicado: (2019)

Giant Cells of Various Lesions Are Characterised by Different Expression Patterns of HLA-Molecules and Molecules Involved in the Cell Cycle, Bone Metabolism, and Lineage Affiliation: An Immunohistochemical Study with a Review of the Literature
por: Hild, Vivien, et al.
Publicado: (2023)

Malignant Transformation of Giant Cell Tumor of Bone and the Association with Denosumab Treatment: A Radiology and Pathology Perspective
por: van Langevelde, K., et al.
Publicado: (2022)

Spondylectomy for Giant Cell Tumor After Denosumab Therapy
por: de Carvalho Cavalcante, Rodrigo Alves, et al.
Publicado: (2016)

Outcome of conservative and surgical treatment of enchondromas and atypical cartilaginous tumors of the long bones: retrospective analysis of 228 patients
por: Omlor, Georg W., et al.
Publicado: (2019)

Drivers underpinning the malignant transformation of giant cell tumour of bone
por: Fittall, Matthew W, et al.
Publicado: (2020)

Combining of serial embolization and denosumab for large sacropelvic giant cell tumor: Case report of 3 cases
por: Ji, Tao, et al.
Publicado: (2017)

Giant-cell tumor of bone: treatment options and role of denosumab
por: Singh, Arun S, et al.
Publicado: (2015)

'Salvage Treatment' of Aggressive Giant Cell Tumor of Bones with Denosumab
por: Vaishya, Raju, et al.
Publicado: (2015)

A Recurrent Giant Cell Tumor of Bone Treated with Denosumab
por: Stadler, Nicola, et al.
Publicado: (2015)

Denosumab for Treatment of a Recurrent Cervical Giant-Cell Tumor
por: Kajiwara, Daisuke, et al.
Publicado: (2016)

Giant cell tumor of a rib following denosumab treatment
por: Semionov, Alexandre, et al.
Publicado: (2018)

Denosumab Therapy for Giant Cell Tumor of Bone Pulmonary Metastasis
por: Egbert, Ryan Carlisle, et al.
Publicado: (2017)

Denosumab in Giant Cell Tumor of Bone: Current Status and Pitfalls
por: Li, Hengyuan, et al.
Publicado: (2020)

Radiological findings of denosumab treatment for giant cell tumours of bone
por: van Langevelde, Kirsten, et al.
Publicado: (2020)

Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum
por: Bukata, Susan V., et al.
Publicado: (2021)

Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone
por: Lipplaa, Astrid, et al.
Publicado: (2019)

A Systematic Review and Illustrative Case Presentation of Low-Grade Myofibroblastic Sarcoma (LGMS) of the Extremities
por: Schenker, Astrid, et al.
Publicado: (2023)

Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab
por: Hakozaki, Michiyuki, et al.
Publicado: (2014)

The dilemma of denosumab: Salvage of a femoral head giant cell tumour
por: Gaston, Czar Louie, et al.
Publicado: (2014)

Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab
por: Mukaihara, Kenta, et al.
Publicado: (2016)

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone
por: Borkowska, Aneta, et al.
Publicado: (2016)

Malignant Sarcomatous Transformation of Benign Giant Cell Tumor of Bone after Treatment with Denosumab Therapy: A Literature Review of Reported Cases
por: Alaqaili, Sadiq I, et al.
Publicado: (2018)

U-RT1 – A new model for Richter transformation
por: Schmid, Teresa, et al.
Publicado: (2020)

Giant cell tumor of the humeral head treated by denosumab: Implication to shoulder surgeons
por: Leung, Ka Hei, et al.
Publicado: (2015)

Two Cases of Sarcoma Arising in Giant Cell Tumor of Bone Treated with Denosumab
por: Broehm, Cory Julian, et al.
Publicado: (2015)

Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone
por: Gaston, Czar Louie, et al.
Publicado: (2016)

Safety and efficacy of denosumab in the treatment of pulmonary metastatic giant cell tumor of bone
por: Luo, Yi, et al.
Publicado: (2018)

Giant Cell Tumors of the Bone: Changes in Image Features after Denosumab Administration
por: Oguro, Sota, et al.
Publicado: (2018)

Denosumab Treatment for Aggressive Multiple Recurrent Familial Central Giant-cell Granulomas
por: Rytkönen, Eelis, et al.
Publicado: (2018)

Evaluation of Local Recurrence in Giant-Cell Tumor of Bone Treated by Neoadjuvant Denosumab
por: Chinder, Pramod Shekarappa, et al.
Publicado: (2019)

Study of imaging changes following preoperative denosumab for giant cell tumor of bone
por: Yang, Yongkun, et al.
Publicado: (2021)

Progress on Denosumab Use in Giant Cell Tumor of Bone: Dose and Duration of Therapy
por: Xiang, Feifan, et al.
Publicado: (2022)

Rotational symmetry of the SU(3) potential
por: Hasenfratz, Anna, et al.
Publicado: (1984)

The beta function of the SU(3) Wilson action
por: Hasenfratz, Anna, et al.
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_i4ls172lfkuekj7g269cn4smac